V930 First in Man (FIM) Study (V930-002)(COMPLETED)
To determine the safety/tolerability, and immunogenicity of an experimental vaccine given as intramuscular injections followed by electrostimulation in cancer patients.
Cancers Expressing HER-2 and/or CEA
BIOLOGICAL: V930
To determine the safety/tolerability, and immunogenicity of an experimental vaccine given as intramuscular injections followed by electrostimulation in cancer patients.